[Skip to Content]
[Skip to Content Landing]
November 8, 2006

Systolic and Nonsystolic Heart Failure: Equally Serious Threats

Author Affiliations

Author Affiliation: Departments of Medicine and Cardiology, Roskilde University Hospital, Roskilde, Denmark.

JAMA. 2006;296(18):2259-2260. doi:10.1001/jama.296.18.2259

Heart failure is a common disease with increasing prevalence, accounting for an estimated 1.1 million hospitalizations annually in the United States.1 Despite development of effective treatments, including β-blockers, angiotensin-converting enzyme inhibitors, spironolactone, defibrillators, and cardiac resynchronization, heart failure remains a serious disease and is associated with a poor prognosis.2